{"id":2573,"date":"2023-12-29T13:36:50","date_gmt":"2023-12-29T10:36:50","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=2573"},"modified":"2023-12-29T13:39:12","modified_gmt":"2023-12-29T10:39:12","slug":"ilac-sektoru-icin-2023-nasil-gecti","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=2573","title":{"rendered":"\u0130la\u00e7 Sekt\u00f6r\u00fc i\u00e7in 2023 Nas\u0131l Ge\u00e7ti?"},"content":{"rendered":"\n

Sava\u015f Malko\u00e7<\/strong><\/p>\n\n\n\n

\u0130E\u0130S Genel Sekreteri<\/strong><\/p>\n\n\n\n

\u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 (\u0130E\u0130S) Genel Sekreteri Sava\u015f Malko\u00e7 ile yerli ila\u00e7 \u00fcretimi ve Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131n \u00f6nemi, 2023 y\u0131l\u0131 ila\u00e7 ihracat rakamlar\u0131, ila\u00e7 ruhsatland\u0131rma, fiyatland\u0131rma ve geri \u00f6deme politikalar\u0131 ile sekt\u00f6r\u00fcn gelecek y\u0131ldan beklentileri \u00fczerine bir s\u00f6yle\u015fi ger\u00e7ekle\u015ftirdik.<\/strong><\/p>\n\n\n\n

\u0130la\u00e7ta yerli \u00fcretimin artmas\u0131n\u0131n, toplumsal sa\u011fl\u0131k, istihdam ve ekonomi \u00fczerindeki katk\u0131lar\u0131ndan s\u00f6z eder misiniz?<\/strong><\/p>\n\n\n\n

G\u00fc\u00e7l\u00fc ve kendine yeterli bir ila\u00e7 end\u00fcstrisine sahip olmak hem toplum sa\u011fl\u0131\u011f\u0131 hem de ekonomik a\u00e7\u0131dan t\u00fcm \u00fclkeler i\u00e7in son derece stratejik bir \u00f6neme sahiptir. Yak\u0131n zamanda ya\u015fad\u0131\u011f\u0131m\u0131z Covid-19 pandemi s\u00fcreci bunu t\u00fcm d\u00fcnyaya ac\u0131 bir \u015fekilde g\u00f6stermi\u015ftir. S\u00fcre\u00e7 ila\u00e7 sekt\u00f6r\u00fcn\u00fcn ayn\u0131 savunma sanayi gibi stratejik \u00f6nemi haiz bir sekt\u00f6r oldu\u011funu net bi\u00e7imde ortaya koymu\u015ftur. Gururla ifade etmeliyiz ki T\u00fcrk ila\u00e7 end\u00fcstrimiz bu s\u00fcre\u00e7te pek \u00e7ok geli\u015fmi\u015f \u00fclkenin dahi ba\u015faramad\u0131\u011f\u0131n\u0131 ba\u015fararak; t\u00fcm maliyet art\u0131\u015flar\u0131, hammaddeye eri\u015fim zorluklar\u0131, lojistik aksamalar ve \u00e7al\u0131\u015fma hayat\u0131ndaki k\u0131s\u0131tlamalara ra\u011fmen, \u00fcretimine kesintisiz devam ederek, \u00fclkemizde ila\u00e7 arz\u0131n\u0131 g\u00fcvence alt\u0131na alm\u0131\u015ft\u0131r.<\/p>\n\n\n\n

Bug\u00fcn \u00fclkemizde y\u00fcksek \u00fcretim teknolojisine ve kapasitesine sahip, kendine yeten, k\u00fcresel rekabette g\u00fcc\u00fcn\u00fc korumak i\u00e7in s\u00fcrekli yat\u0131r\u0131m yapan ve \u00e7al\u0131\u015fan \u00e7ok k\u00f6kl\u00fc, g\u00fc\u00e7l\u00fc ve deneyimli bir ila\u00e7 end\u00fcstrisi mevcuttur. Uluslararas\u0131 standartlarda 109 ila\u00e7, 13 hammadde \u00fcretim tesisimiz bulunmaktad\u0131r. \u00dclkemizde kullan\u0131lan her 100 ila\u00e7tan 91\u2019i bu tesislerde \u00fcretilmektedir. 2008 y\u0131l\u0131nda sadece 1 olan ve bug\u00fcn say\u0131s\u0131 42\u2019ye ula\u015fan Ar-Ge merkezimizle katma de\u011ferli ve teknoloji yo\u011fun bir sekt\u00f6r\u00fcz.<\/p>\n\n\n\n

Yerli ve milli ila\u00e7 end\u00fcstrisini desteklemek toplum sa\u011fl\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan oldu\u011fu kadar ekonomik a\u00e7\u0131dan da b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. Nitekim, yerli end\u00fcstrinin desteklenmesi yurt i\u00e7i ila\u00e7 \u00fcretiminin artmas\u0131na, \u00fcretim tesislerindeki at\u0131l kapasitenin kullan\u0131ma kazand\u0131r\u0131lmas\u0131na, yeni yat\u0131r\u0131mlar\u0131n ve tesislerin olu\u015fmas\u0131na, bu sayede \u00fcretim teknolojilerinin geli\u015fmesine, istihdama katk\u0131n\u0131n artmas\u0131na, yurt i\u00e7inde \u00fcretilen ila\u00e7lar\u0131n ihracat\u0131 ve ithal edilen \u00fcr\u00fcnlerin \u00fcretimine ba\u015flanarak cari a\u00e7\u0131\u011f\u0131n kapat\u0131lmas\u0131na b\u00fcy\u00fck katk\u0131 sunacakt\u0131r.<\/p>\n\n\n\n

T\u00fcrkiye\u2019nin ila\u00e7 ihracat\u0131ndaki durumundan s\u00f6z eder misiniz? 2023 y\u0131l\u0131 ihracat rakamlar\u0131 nedir? \u00d6nceki y\u0131llara g\u00f6re bu sene nas\u0131l bir seyir g\u00f6sterdi? T\u00fcrkiye\u2019nin potansiyeli dikkate al\u0131nd\u0131\u011f\u0131nda ula\u015fmam\u0131z gereken nokta i\u00e7in neler s\u00f6ylersiniz?<\/strong><\/p>\n\n\n\n

D\u00fcnya standartlar\u0131nda \u00fcretim g\u00fcc\u00fcm\u00fcz ve kapasitemiz mevcut. Bununla beraber d\u0131\u015f ticarette hen\u00fcz d\u00fcnya pazar\u0131nda yeterli rekabet g\u00fcc\u00fcne sahip de\u011filiz. \u0130la\u00e7 ihracat\u0131nda \u00fclkemiz %0,2 pay ile d\u00fcnyada 29. s\u0131rada yer al\u0131yor. G\u00fc\u00e7l\u00fc yap\u0131m\u0131z ile \u00fclkemizin geli\u015fmekte olan pazarlara olan lojistik avantajlar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda end\u00fcstrimiz, d\u00fcnya ila\u00e7 ihracat\u0131 i\u00e7indeki pay\u0131n\u0131 \u00e7ok daha yukar\u0131lara ta\u015f\u0131yacak potansiyele sahip.  Y\u00fcksek teknoloji s\u0131n\u0131f\u0131nda olan katma de\u011feri y\u00fcksek ila\u00e7 sekt\u00f6r\u00fcn\u00fcn ihracat\u0131n\u0131n art\u0131r\u0131lmas\u0131 \u00fclkemiz d\u0131\u015f ticaret a\u00e7\u0131\u011f\u0131n\u0131n gerilemesi a\u00e7\u0131s\u0131ndan da b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor.<\/p>\n\n\n\n

Bu alanda end\u00fcstrimizin geli\u015fimi i\u00e7in hem \u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 hem de koordinasyonumuzda faaliyetlerini y\u00fcr\u00fcten T\u00fcrkiye \u0130la\u00e7 \u0130hracat\u00e7\u0131lar\u0131 Platformumuz \u00e7at\u0131s\u0131 alt\u0131nda \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 s\u00fcrd\u00fcr\u00fcyoruz. Nitekim firmalar\u0131m\u0131z\u0131n bu alandaki yo\u011fun \u00e7al\u0131\u015fmalar\u0131yla, ihracat\u0131m\u0131z son y\u0131llarda \u00f6nemli bir at\u0131l\u0131m i\u00e7inde. End\u00fcstrimiz; Avrupa Birli\u011fi, Ba\u011f\u0131ms\u0131z Devletler Toplulu\u011fu, Kuzey Afrika ve Orta Do\u011fu \u00fclkeleri ba\u015fta olmak \u00fczere 190 \u00fclkeye ihracat ger\u00e7ekle\u015ftiriyor.<\/p>\n\n\n\n

2023 y\u0131l\u0131n\u0131n ilk on ayl\u0131k d\u00f6neminde T\u00fcrkiye ihracat\u0131 %0,2 oran\u0131nda b\u00fcy\u00fcme g\u00f6sterirken, ila\u00e7 ihracat\u0131 %20 art\u0131\u015f ile 1.837,6 milyon ABD Dolar\u0131 seviyesine ula\u015fm\u0131\u015ft\u0131r. 12 ayl\u0131k d\u00f6nem incelendi\u011finde ise T\u00fcrkiye ihracat\u0131 bir \u00f6nceki d\u00f6neme g\u00f6re %0,6 art\u0131\u015fla 254,7 milyar ABD Dolar\u0131\u2019na ula\u015f\u0131rken, ila\u00e7 ihracat\u0131 y\u0131ll\u0131k bazda %14,5 art\u0131\u015fla 2,2 milyar ABD Dolar\u0131 seviyesine gelmi\u015ftir.<\/p>\n\n\n\n

\u0130la\u00e7 end\u00fcstrimiz 2020 y\u0131l\u0131nda ihracatta ula\u015ft\u0131\u011f\u0131 rekor art\u0131\u015f\u0131 sonraki y\u0131llarda maalesef devam ettirememi\u015f, 2021 ve 2022 y\u0131llar\u0131nda, ula\u015ft\u0131\u011f\u0131 seviyede dura\u011fan bir seyir izlemi\u015ftir. \u0130hracatta son y\u0131llarda sa\u011flanan ba\u015far\u0131n\u0131n kal\u0131c\u0131 olmas\u0131 ve daha da ileri gitmesi i\u00e7in bu alanda ya\u015fanan sorunlara h\u0131zla \u00e7\u00f6z\u00fcm \u00fcretilmesi b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor. Bug\u00fcn ihracat\u0131m\u0131z\u0131n \u00f6zellikle de\u011fer baz\u0131nda artmas\u0131n\u0131n \u00f6n\u00fcnde baz\u0131 yap\u0131sal sorunlar mevcut. Bunlar\u0131n ba\u015f\u0131nda da \u00fclkemizde uygulanan ila\u00e7 fiyat politikas\u0131 geliyor.<\/p>\n\n\n\n

\u00dclkemizde ila\u00e7lar\u0131n fiyatland\u0131r\u0131lmas\u0131 referans fiyat sistemine g\u00f6re yap\u0131lmakta olup, Avro cinsinden referans fiyat\u0131n TL\u2019ye \u00e7evrilmesi i\u00e7in g\u00fcncel Avro kuru yerine bir \u00f6nceki y\u0131l\u0131n ortalama Avro de\u011ferinin %60\u2019\u0131 al\u0131narak belirlenen sabit bir ila\u00e7 kuru kullan\u0131l\u0131yor. Mevcut ila\u00e7 kuru uygulamas\u0131 nedeniyle, d\u00fcnya fiyatlar\u0131 ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda \u00fclkemizdeki ila\u00e7 fiyatlar\u0131 son derece d\u00fc\u015f\u00fck seviyelerde kal\u0131yor ve bu fiyatlar ihra\u00e7 pazarlar\u0131nda bizim kar\u015f\u0131m\u0131za referans olarak \u00e7\u0131k\u0131yor. Dolay\u0131s\u0131yla ihra\u00e7 fiyatlar\u0131m\u0131z d\u00fczenli bi\u00e7imde d\u00fc\u015f\u00fcyor ve ihra\u00e7 gelirlerimizin artmas\u0131n\u0131n \u00f6n\u00fcnde engel olu\u015fturuyor. Nitekim, yak\u0131n zamana kadar 40 dolar d\u00fczeyinde olan birim ihra\u00e7 fiyatlar\u0131m\u0131z 24 dolara kadar gerilemi\u015ftir.<\/p>\n\n\n\n

\u0130E\u0130S olarak \u00f6ncelikli beklentilerimizden birisi de yurt i\u00e7i \u00fcretimin ve tedarikte yerelle\u015fmenin \u00f6zendirilmesidir. \u0130la\u00e7 \u00fcretiminde ithalat\u0131na ba\u011fl\u0131 oldu\u011fumuz girdilerin ve etkin maddelerin \u00fclkemizde \u00fcretilmesinin ve tedarik edilmesinin sa\u011flanmas\u0131, ila\u00e7ta tecr\u00fcbe etti\u011fimiz d\u0131\u015f ticaret a\u00e7\u0131\u011f\u0131n\u0131n azalt\u0131lmas\u0131na b\u00fcy\u00fck katk\u0131 sa\u011flayacakt\u0131r.<\/p>\n\n\n\n

Son olarak, bilindi\u011fi \u00fczere bug\u00fcn d\u00fcnya ila\u00e7 end\u00fcstrisinde biyoteknoloji devrimi ya\u015fan\u0131yor. Bu ila\u00e7lar sayesinde art\u0131k pek \u00e7ok hastal\u0131\u011f\u0131n tedavisi m\u00fcmk\u00fcn hale geldi. \u00dclkemizde ise biyoteknolojik \u00fcr\u00fcnlerin neredeyse tamam\u0131n\u0131 ithal \u00fcr\u00fcnler olu\u015fturuyor. Toplam ila\u00e7 ithalat\u0131m\u0131zda biyoteknolojik ila\u00e7lar\u0131n pay\u0131n\u0131n %38’e kadar ula\u015fm\u0131\u015f durumda. \u0130thalata dayal\u0131 biyoteknolojik ila\u00e7 tedarik modelinin s\u00fcrd\u00fcr\u00fclebilir olmad\u0131\u011f\u0131 dikkate al\u0131nd\u0131\u011f\u0131nda \u00fclkemizin biyobenzer ila\u00e7lar\u0131n \u00fcreticisi ve ihracat\u00e7\u0131s\u0131 olma hedefine katk\u0131 sa\u011flayacak ruhsatland\u0131rma, fiyatland\u0131rma, te\u015fvik ve geri \u00f6deme politikalar\u0131n\u0131n uygulanmas\u0131n\u0131 kritik \u00f6nemde buluyoruz.<\/p>\n\n\n\n

2023 y\u0131l\u0131 ila\u00e7 sekt\u00f6r\u00fc i\u00e7in nas\u0131l ge\u00e7ti?<\/strong><\/p>\n\n\n\n

End\u00fcstri olarak 2023 y\u0131l\u0131n\u0131, hem \u00fclkemizin uzun y\u0131llard\u0131r g\u00f6rmedi\u011fi y\u00fcksek enflasyon ve TL\u2019nin h\u0131zl\u0131 de\u011fer kayb\u0131 hem de end\u00fcstrimize y\u00f6nelik uygulamada olan mevzuat nedeniyle b\u00fcy\u00fck bir bask\u0131 ve zorluk alt\u0131nda ge\u00e7irdik.<\/p>\n\n\n\n

\u015eubat ay\u0131nda \u00fclkemizi derinden sarsan deprem felaketleri nedeniyle ila\u00e7 end\u00fcstrisi olarak y\u0131l\u0131n ilk d\u00f6nemini Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131m\u0131z ve T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumumuz ile koordinasyon i\u00e7inde b\u00f6lge halk\u0131n\u0131n ihtiya\u00e7 duydu\u011fu ila\u00e7lar\u0131 ivedilikle tedarik etme \u00e7al\u0131\u015fmalar\u0131na adad\u0131k. Di\u011fer yandan ba\u015fta i\u015fg\u00fcc\u00fc, etkin madde, enerji ve ambalaj malzemeleri olmak \u00fczere \u00fcretim maliyetlerindeki astronomik y\u00fckseli\u015flerle m\u00fccadele etmek zorunda kald\u0131k. Bir de bu maliyetlerin \u00fczerine EYT yasas\u0131 ve deprem vergisinin finansman y\u00fckleri eklendi.<\/p>\n\n\n\n

Bunlar\u0131n yan\u0131nda \u00f6zellikle fiyatland\u0131rma ve geri \u00f6deme politikalar\u0131n\u0131n sadece kamu maliyesi bak\u0131\u015f\u0131yla belirlenmeye devam etmesi, sekt\u00f6r\u00fcm\u00fcz\u00fcn sorunlar\u0131n\u0131 daha da i\u00e7inden \u00e7\u0131k\u0131lmaz bir hale getirdi. Geldi\u011fimiz noktada, \u00e7ok uzun y\u0131llard\u0131r devam eden ve son y\u0131llarda daha da s\u0131k\u0131nt\u0131l\u0131 bir hal alan mali sorunlar nedeniyle, y\u00fcksek katma de\u011fer ve ileri teknolojiye dayanan yap\u0131s\u0131 gere\u011fi, di\u011fer sekt\u00f6rlerden farkl\u0131 olarak s\u00fcrekli yat\u0131r\u0131m yapmak ve kendini yenilemek zorunda olan end\u00fcstrimiz ba\u015fta Ar-Ge olmak \u00fczere y\u00fcksek teknolojili yat\u0131r\u0131mlar\u0131n\u0131 da finanse edemez hale geldi.<\/p>\n\n\n\n

Ya\u015fad\u0131\u011f\u0131m\u0131z mali sorunlar\u0131n ana nedenini kamu b\u00fct\u00e7esinden ilaca ayr\u0131lan pay\u0131n y\u0131llar i\u00e7inde azalmas\u0131 olu\u015fturuyor. Nitekim, 2009 y\u0131l\u0131nda %1,6 olan ila\u00e7 harcamalar\u0131n\u0131n \u00fclkemiz Gayrisafi Yurt \u0130\u00e7i Has\u0131las\u0131 i\u00e7indeki pay\u0131, 2022 y\u0131l\u0131nda %0,68 gibi tarihin en d\u00fc\u015f\u00fck d\u00fczeyine kadar gerilemi\u015ftir. Orta Vadeli Plan\u2019\u0131n \u00f6ng\u00f6r\u00fclerine bak\u0131ld\u0131\u011f\u0131nda 2023 y\u0131l\u0131nda da bu oran\u0131n %0,7 d\u00fczeyinde kalmaya devam edece\u011fi anla\u015f\u0131lmaktad\u0131r.<\/p>\n\n\n\n

D\u00fcnyan\u0131n en kapsaml\u0131 sa\u011fl\u0131k sistemlerinden birisine sahip \u00fclkemizin, ya\u015flanan ve artan n\u00fcfusuna yeterli sa\u011fl\u0131k hizmeti sunabilmesi i\u00e7in uygun bir b\u00fct\u00e7eyi tahsis etmesi art\u0131k elzem hale gelmi\u015f durumda. Dolay\u0131s\u0131yla, ilaca ayr\u0131lan kamu b\u00fct\u00e7esinin GSY\u0130H i\u00e7indeki pay\u0131n\u0131n, 2002-2021 y\u0131l\u0131 ortalamas\u0131 olan %1,1 d\u00fczeyine \u00e7\u0131kart\u0131lmas\u0131 b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor.<\/p>\n\n\n\n

Bu ko\u015fullar alt\u0131nda 2023 y\u0131l\u0131n\u0131n ilk 10 ay\u0131nda, \u00fclkemiz ila\u00e7 pazar\u0131 167 milyar TL d\u00fczeyine, miktar baz\u0131nda ise 2,2 milyar kutu seviyesine ula\u015ft\u0131. T\u00fcm zorlay\u0131c\u0131 ko\u015fullara ra\u011fmen \u00fcretimine kesintisiz devam eden end\u00fcstrimiz, y\u0131l\u0131n ilk 10 ay ortalamas\u0131 ile bir \u00f6nceki senenin ayn\u0131 d\u00f6nemi kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda \u00fcretimini %1,9 art\u0131rd\u0131. Ayn\u0131 d\u00f6nemde imalat sanayi \u00fcretimi %1,7 art\u0131\u015f, kimya sekt\u00f6r\u00fc \u00fcretimi %8,7 azal\u0131\u015f g\u00f6sterirken, \u00fclkemizin toplam sanayi \u00fcretim art\u0131\u015f\u0131 ise %1,2 olarak ger\u00e7ekle\u015fti.<\/p>\n\n\n\n

\u0130la\u00e7 fiyatland\u0131rma, geri \u00f6deme ve ruhsatland\u0131rma s\u00fcre\u00e7lerinde T\u00fcrkiye\u2019deki genel durumu nas\u0131l de\u011ferlendirirsiniz? Bu konudaki sorunlara ili\u015fkin \u0130E\u0130S\u2019in \u00e7\u00f6z\u00fcm \u00f6nerileri nedir?<\/strong><\/p>\n\n\n\n

\u0130la\u00e7 end\u00fcstrisi olarak en hayati sorunumuz art\u0131k ya\u015fad\u0131\u011f\u0131m\u0131z ekonomik ko\u015fullarda tamamen i\u015flevini yitirmi\u015f olan fiyat mevzuat\u0131d\u0131r. Bilindi\u011fi \u00fczere, \u00fclkemizde uygulanan referans fiyat sistemine g\u00f6re ila\u00e7 fiyatlar\u0131 Fransa, \u0130talya, \u0130spanya, Portekiz ve Yunanistan\u2019daki depocuya sat\u0131\u015f fiyatlar\u0131ndan en ucuzunun referans fiyat olarak kabul edilmesiyle belirlenmekte ve Avro cinsinden olan bu fiyatlar TL\u2019ye \u00e7evrilerek ila\u00e7 kuru tespit edilmektedir.<\/p>\n\n\n\n

\u0130la\u00e7 kuru y\u0131lda 1 kere, \u015eubat sonunda olmak kayd\u0131yla ge\u00e7mi\u015f y\u0131l\u0131n ortalama Avro kurunun sadece %60\u2019\u0131 al\u0131narak belirlenmektedir. D\u00f6viz kurundaki dalgalanmalar nedeniyle ila\u00e7 kuru 2022 ve 2023 y\u0131llar\u0131nda ilk kez 2 defa g\u00fcncellenmek zorunda kalm\u0131\u015ft\u0131r. 2023 ve 2024 y\u0131l\u0131 ila\u00e7 kurlar\u0131 ise \u015eubat ay\u0131 beklenmeden \u00f6nceki senenin Aral\u0131k ay\u0131nda a\u00e7\u0131klanm\u0131\u015ft\u0131r. T\u00fcm bu ek tedbirlere ra\u011fmen ila\u00e7 kuruyla g\u00fcncel kur aras\u0131ndaki makas\u0131n a\u00e7\u0131lmas\u0131 durdurulamamaktad\u0131r. Aral\u0131k 2023\u2019teki son g\u00fcncellemeyle ila\u00e7 kuru 17.5483 TL olarak belirlenmi\u015ftir. Bu g\u00fcncelleme, az da olsa ila\u00e7 end\u00fcstrimize nefes ald\u0131rm\u0131\u015ft\u0131r. Ancak g\u00fcncel piyasa kurunun sadece %55\u2019ine tekab\u00fcl eden bu oranla ileri teknolojiye dayanan ve kesintisiz yat\u0131r\u0131m gerektiren end\u00fcstrimizi ayakta tutmam\u0131z m\u00fcmk\u00fcn de\u011fil.  Bu konuda halen ilave ad\u0131mlar at\u0131lmas\u0131 gerekti\u011fini d\u00fc\u015f\u00fcn\u00fcyoruz. Bu kapsamda son 2 y\u0131lda oldu\u011fu gibi, 2024 y\u0131l\u0131 i\u00e7inde de ila\u00e7 kurunda ilave bir art\u0131\u015f yap\u0131lmas\u0131n\u0131 elzem olarak de\u011ferlendiriyoruz.<\/p>\n\n\n\n

B\u00f6ylesi k\u0131sa vadeli \u00e7\u00f6z\u00fcmlerin end\u00fcstrimizi gelece\u011fe ta\u015f\u0131mas\u0131 m\u00fcmk\u00fcn de\u011fildir. Ya\u015fad\u0131\u011f\u0131m\u0131z s\u00fcre\u00e7, mevcut ila\u00e7 fiyatland\u0131rma mevzuat\u0131n\u0131n g\u00fcn\u00fcm\u00fcz\u00fcn ekonomik ve mali ko\u015fullar\u0131na g\u00f6re k\u00f6kl\u00fc bir reforma tabi tutulmas\u0131n\u0131n art\u0131k ka\u00e7\u0131n\u0131lmaz oldu\u011funu a\u00e7\u0131k\u00e7a g\u00f6stermektedir. Yeni ila\u00e7 fiyat mevzuat\u0131nda; referans fiyat sistemi korunmal\u0131, ancak aksayan y\u00f6nleri d\u00fczeltilmelidir.  Bu kapsamda; yeni mevzuatta 5 kaynak \u00fclkeden fiyat\u0131 en d\u00fc\u015f\u00fck olan de\u011fil; 5 kaynak \u00fclkenin fiyat\u0131n\u0131n aritmetik ortalamas\u0131 esas al\u0131nmal\u0131d\u0131r. Ayr\u0131ca, ila\u00e7 kuru belirlenirken bir \u00f6nceki y\u0131l\u0131n ortalama Avro de\u011ferinin % 60\u2019\u0131 yerine % 100\u2019\u00fc al\u0131nmal\u0131 ve \u015eubat ay\u0131 sonunda de\u011fil, y\u0131l\u0131n ilk i\u015f g\u00fcn\u00fc devreye girmeli, bu kur y\u0131lda 1 defa de\u011fil her 6 ayda bir g\u00fcncellenmelidir. Bu alana dair t\u00fcm \u00e7\u00f6z\u00fcm \u00f6nerilerimizi ilgili kamu kurumlar\u0131m\u0131zla payla\u015fmaya devam ediyoruz.<\/p>\n\n\n\n

End\u00fcstrimizi mali a\u00e7\u0131dan zorlayan bir di\u011fer sorun SGK\u2019n\u0131n geri \u00f6deme politikalar\u0131d\u0131r. Zaten ila\u00e7 kuru politikas\u0131 nedeniyle d\u00fc\u015f\u00fck ila\u00e7 fiyat\u0131 alan end\u00fcstrimiz buna ilave olarak SGK\u2019ya %41\u2019lere varan iskontolar yapmak zorundad\u0131r. Fiyatland\u0131rma ve geri \u00f6deme alan\u0131ndaki bu uygulamalar\u0131n\u0131n sonucunda \u00fclkemizdeki ila\u00e7 fiyatlar\u0131 hammaddeyi ald\u0131\u011f\u0131m\u0131z Hindistan\u2019da \u00fcretilen ila\u00e7lar\u0131n bile fiyatlar\u0131ndan daha d\u00fc\u015f\u00fck hale gelmi\u015ftir. Bu nedenle, iskonto oranlar\u0131nda gecikmeksizin her bir kategoride 18 puanl\u0131k indirim yap\u0131lmas\u0131 ve h\u00e2lihaz\u0131rda iskonto oran\u0131 s\u0131f\u0131r olan ila\u00e7larda 18 puanl\u0131k ilave \u00f6deme ger\u00e7ekle\u015ftirilmesi end\u00fcstrimiz i\u00e7in b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. \u00c7ok uzun y\u0131llard\u0131r ila\u00e7 geri \u00f6deme politikalar\u0131 sadece kamu maliyesi bak\u0131\u015f\u0131yla belirlenmekte, hastalar\u0131n ila\u00e7lara eri\u015fimi ve T\u00fcrk ila\u00e7 end\u00fcstrimizin gelece\u011fi perspektifleri g\u00f6z ard\u0131 edilmektedir. Bunun en \u00e7arp\u0131c\u0131 \u00f6rneklerinden birisi, son yay\u0131mlanan SGK \u0130la\u00e7 Geri \u00d6deme Y\u00f6netmeli\u011fi\u2019nde yer alan, biyobenzer \u00fcr\u00fcnlerin geri \u00f6deme ba\u015fvurular\u0131nda \u00f6nceliklendirilmesi i\u00e7in getirilen referans fiyat\u0131n %30 alt\u0131nda birim fiyat ile ba\u015fvuruda bulunma zorunlulu\u011fudur. Bu karar, uzun y\u0131llard\u0131r b\u00fct\u00fcn birikimini, deneyimini ve sermayesini bu alana yat\u0131ran, bu sayede bug\u00fcn bu alanda \u00fcretime ba\u015flam\u0131\u015f 9 aktif tesisinde 34 biyobenzer ilac\u0131n \u00fcretimi yapan, 6 tesisi de tamamlanma a\u015famas\u0131nda olan end\u00fcstrimizi cezaland\u0131r\u0131r niteliktedir. Bu uygulamadan vazge\u00e7ilmesi en \u00f6ncelikli beklentimizdir.<\/p>\n\n\n\n

\u0130la\u00e7 gibi d\u0131\u015fsall\u0131\u011f\u0131 \u00e7ok y\u00fcksek bir sekt\u00f6r i\u00e7in kamu taraf\u0131ndan yap\u0131lacak harcamalar\u0131n bir maliyet unsuru olarak de\u011fil, \u00fclkemizin toplam verimlili\u011fini art\u0131racak \u2018be\u015feri sermaye yat\u0131r\u0131m\u0131\u2019 olarak de\u011ferlendirilmesi b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. Yeni bak\u0131\u015f a\u00e7\u0131s\u0131yla geri \u00f6deme politikalar\u0131m\u0131z\u0131n da ayn\u0131 fiyatland\u0131rma politikalar\u0131nda oldu\u011fu gibi revize edilmesi zorunluluk halini alm\u0131\u015ft\u0131r.<\/p>\n\n\n\n

Ruhsat ba\u015fvurular\u0131n\u0131n h\u0131zl\u0131 ve \u00f6ng\u00f6r\u00fclebilir bir \u015fekilde sonu\u00e7land\u0131r\u0131lmas\u0131 da sekt\u00f6r\u00fcm\u00fcz\u00fcn \u00f6ncelikli sorunlar\u0131ndan birisidir. 2020 y\u0131l\u0131ndan beri bu alanda ya\u015fad\u0131\u011f\u0131m\u0131z t\u0131kan\u0131kl\u0131k b\u00fcy\u00fck oranda \u00e7\u00f6z\u00fcme kavu\u015fmu\u015f durumda. Ancak t\u00fcm ilerlemeye ra\u011fmen Avrupa Birli\u011fi\u2019nde oldu\u011fu gibi 210 g\u00fcn ile s\u0131n\u0131rland\u0131r\u0131lm\u0131\u015f olan \u00fclkemizdeki ruhsatland\u0131rma s\u00fcre\u00e7lerinde belirsizlik devam etmekte, 210 g\u00fcn hedefi tutturulamamaktad\u0131r.<\/a> S\u00fcre\u00e7lerdeki belirsizliklerin ve s\u00fcrecin i\u015flemesini engelleyici yakla\u015f\u0131mlar\u0131n \u00f6n\u00fcne ge\u00e7mek i\u00e7in kurumumuzla bir araya gelerek t\u00fcm konular\u0131 de\u011ferlendiriyoruz. Umut ediyoruz ki bu alandaki sorunlar\u0131m\u0131za y\u00f6nelik kal\u0131c\u0131 \u00e7\u00f6z\u00fcmler olu\u015fturur ve en k\u0131sa s\u00fcrede belirsizlikleri ortadan kald\u0131rd\u0131\u011f\u0131m\u0131z bir sisteme ge\u00e7i\u015f yapar\u0131z.\u00a0<\/p>\n\n\n\n

2024 y\u0131l\u0131 beklentileriniz neler?<\/strong><\/p>\n\n\n\n

2024 y\u0131l\u0131ndan beklentimiz, \u00f6ncelikle end\u00fcstrimizin acil \u00e7\u00f6z\u00fcm bekleyen, fiyat ve geri \u00f6deme politikalar\u0131 ba\u015fta olmak \u00fczere yap\u0131sal sorunlar\u0131n\u0131n \u00e7\u00f6z\u00fcm\u00fcne y\u00f6nelik kapsaml\u0131 ve etkili politikalar olu\u015fturulmas\u0131d\u0131r. Biz de art\u0131k Cumhuriyetimizin 2. y\u00fczy\u0131l\u0131na ad\u0131m att\u0131\u011f\u0131m\u0131z bu senede mali ve teknik sorunlar\u0131 de\u011fil, gelece\u011fimize y\u00f6n verecek trendlerin haz\u0131rl\u0131\u011f\u0131n\u0131 ana konular\u0131m\u0131z haline getirmek istiyoruz.<\/p>\n\n\n\n

T\u00fcm zorluklara ra\u011fmen, \u00fclkemizde \u00e7ok g\u00fc\u00e7l\u00fc bir yerli ve milli ila\u00e7 end\u00fcstrisi var. Tart\u0131\u015fmas\u0131z \u015fekilde stratejik \u00f6nem ta\u015f\u0131yan ve t\u00fcm olumsuzluklara ra\u011fmen \u00fclkemizde kullan\u0131lan her 100 ilac\u0131n 91\u2019ini yurt i\u00e7inde \u00fcretme ba\u015far\u0131s\u0131n\u0131 g\u00f6steren, uluslararas\u0131 standartlarda \u00fcretim tesislerine sahip olan sekt\u00f6r\u00fcm\u00fcz\u00fc gelece\u011fe ta\u015f\u0131yacak, g\u00fcc\u00fcne g\u00fc\u00e7 katacak uzun d\u00f6nemli ve dengeli politikalarla T\u00fcrk ila\u00e7 end\u00fcstrimizin k\u00fcresel \u00e7apta bir g\u00fcce ula\u015faca\u011f\u0131na \u015f\u00fcphemiz yok.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 (\u0130E\u0130S) Genel Sekreteri Sava\u015f Malko\u00e7 ile yerli ila\u00e7 \u00fcretimi ve Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131n \u00f6nemi, 2023 y\u0131l\u0131 ila\u00e7 ihracat rakamlar\u0131, ila\u00e7 ruhsatland\u0131rma, fiyatland\u0131rma ve geri \u00f6deme politikalar\u0131 ile sekt\u00f6r\u00fcn gelecek y\u0131ldan beklentileri \u00fczerine bir s\u00f6yle\u015fi ger\u00e7ekle\u015ftirdik.<\/p>\n","protected":false},"author":1,"featured_media":2576,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,2],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2573"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2573"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2573\/revisions"}],"predecessor-version":[{"id":2575,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2573\/revisions\/2575"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/2576"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}